Navigation Links
National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
Date:9/19/2007

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- Recognizing the devastating toll substance use conditions take on our nation's health, the National Quality Forum (NQF) today, for the first time ever, released a groundbreaking set of endorsed national voluntary consensus standards on evidence-based practices to treat substance use conditions. The standards were developed with support from the Robert Wood Johnson Foundation.

Substance use problems and illnesses have substantial impact on health and societal costs, and often are linked to catastrophic personal consequences. Data from the 2005 National Survey on Drug Use and Health reveal that an estimated 22.2 million persons aged 12 or older met diagnostic criteria for substance dependence or abuse with alcohol or illicit drugs in the past year, and an estimated 71.5 million used a tobacco product within the previous month(1).

"We cannot effectively address the disturbing effects of excessive drug and alcohol use without quality treatment for people with substance use conditions," said Janet Corrigan, PhD, NQF President and CEO. "NQF believes these standards will accelerate the use of effective, evidence-based treatments."

During the past 15 years, scientific knowledge about evidence-based therapies to treat people with substance use conditions has increased substantially. The NQF consensus standards provide clear guidance to the field on evidence-based practices that if adopted in all health care settings would substantially improve patient outcomes. The NQF report also identifies areas where further research is needed to identify preferred treatment practices and provides recommendations for the development of quality measures to evaluate and improve performance.

The endorsement of these practices by NQF's over 365 member organizations, which include healthcare providers, consumer groups, professional associations, purchasers, federal and state agencies, research and quality improvemen
'/>"/>

SOURCE National Quality Forum
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. International community warns India on HIV situation
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Key step forward on International Health Rules
6. ICMR along with other International Research organisation with drug development for Neglected Diseases
7. International Osteoporosis Research Centre To Be Started In India.
8. Hepatitis B Vaccine To Be Included In National Immunization Programme
9. Indian hospitals require International Accreditation
10. International Conference On Malaria - Laveran To Genomics
11. UK Govt Says On Course For National Chlamydia Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)... Annually, allergies and asthma strike,one out of ...eezing and,wheezing -- as well as $6 billion in do... right air treatment and cleaning strategies in,pl...ving environment and,help avoid allergy suffering,...ident of Sylvane.com ( http://www.sylvane.com )., ...
(Date:5/12/2008)...ered treatments which have helped millions of peop...diseases have been awarded the prestigious 2008 Dr...unced today. , Emeritus Professor Sir Ravinder M...rrying out research together at Imperial College L... award by an international committee including Nob...
(Date:5/12/2008)...AGEN, Denmark, May 12,/PRNewswire-FirstCall/ -- Wa...the United States Food and Drug Administration (FD... Taclonex Scalp(R) (calcipotriene 0.005% and,betam...LEO Pharma submitted,the NDA for Taclonex Scalp(R)...opical suspension containing a combination of calc...
(Date:5/12/2008)...RNewswire/ -- Emphasys Medical Inc.,today announc... of the,company,s Zephyr(R) Endobronchial Valve (E...nce of the American Thoracic Society (ATS) occurri...18, 9:30-11:00 a.m. (ET), Metro Toronto Convention...s in Emphysema Treatment: Lung Volume,Reduction an...
Breaking Medicine News(10 mins):Health News:Simple Steps to a Healthier, Allergy-Free Home 2Health News:Simple Steps to a Healthier, Allergy-Free Home 3Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 2Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 3Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 4Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 2Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 3Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 4Health News:Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008 2
...particles in occupational settings and in the envi...r risk. The December// Journal of Occupational and...he American College of Occupational and Environmen...ue providing updates on particles and cancer. "A ...
...red that women treated for ovarian cancer are at i...urrence if their tumor cells have high// levels of...nd slows down cell death, both hallmarks of malign...at testing for NAC-1 protein in cancer tissue remo...
...BIC) is a natural soy-based substance. A US based ...s with a disease similar to multiple// sclerosis. ...tis (EAE) received BBIC, while another group of an...he same disease received a placebo. "Animals that...
...mammography unit can detect breast tumors as tiny ...e it a valuable complementary// imaging technique ...o helped develop the technology along with industr...ealthcare. This new technique, Molecular Breast ...
Other Medicine News:Health News:Inhaled Particles Increases the Risk of Lung Cancer 2Health News:'Clumping' Protein Linked to Return of Ovarian Cancer 2Health News:A New Gamma Camera Technique for the Detection of Small Breast Tumors 2Health News:A New Gamma Camera Technique for the Detection of Small Breast Tumors 3
(Date:5/8/2008)...trated significant improvement in ADHD symptoms in... -- Shire plc (LSE: SHP,Nasdaq: SHPGY), the globa...nted the results of a phase III pivotal study in w... in Attention Deficit Hyperactivity,Disorder (ADHD...cy,endpoints., "Adults with ADHD often find it ch...
(Date:5/8/2008)... May 8 /- Alpharma Inc. (NY...any, today announced results from,clinical trials ...extended-release with sequestered naltrexone hydro...t features addressing abuse liability,alongside a ... and II,studies, presented at the 27th Annual Scie...
(Date:5/8/2008)...ovides "Blueprint" to Produce Therapeutic Proteins.../PRNewswire-USNewswire/ -- Using gene,therapy, pla...ins through,skin flaps placed on cancerous tumors ...e, according to a study in the May issue of Plasti...cal journal of the American,Society of Plastic Sur...
(Date:5/8/2008)...ed at the 27th Annual Meeting of the American Pain...MYRNA, Ga., May 8 /- Patients treated...f from diabetic neuropathic pain (DNP),compared t...ented at the,27th annual meeting of the American P...rst placebo-controlled trial of a diabetic neuropa...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4Can you rescue a rainforest 3F The answer may be yes 2647 1Can you rescue a rainforest 3F The answer may be yes 2647 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 1IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 3Schizophrenia Tied to Multiple Genetic Errors 15335 1Schizophrenia Tied to Multiple Genetic Errors 15335 2Schizophrenia Tied to Multiple Genetic Errors 15335 3California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 1California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 2California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 3California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 4
...RE , England, 21 June 2007, Malvern Instruments ha...f the company,s,near infrared chemical imaging (NI... on 13 June 2007 was hosted by AstraZeneca in,Macc...orld,s major,pharmaceutical companies joined Malve...that included oral and poster presentations on,the...
...INESS WIRE)--Jun 20, 2007 - Senator Obama today,re...ident Bush,s,veto of Stem Cell Bill:, "By vetoing ...sident is deferring the hopes of millions of Ameri...the cure that may save or,extend their lives. The ...y particular ideology, it is the judgment of scien...
Other Medicine Technology:Malvern initiates European user group meetings for chemical imaging 2Malvern initiates European user group meetings for chemical imaging 3
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: